- Medicine - 08:00 Sandoz invites young entrepreneurs to enter Sandoz HACk, a global competition to help solve healthcare access challenges
- Medicine - 06:01 Researchers trial diabetes app
- Medicine - Sep 28 Creating healthy cities one step at a time
- Life Sciences - Sep 27 Clean house
- Medicine - Sep 27 Universal flu vaccine designed by scientists
- Medicine - Sep 27 Implicit bias may help explain high preschool expulsion rates for black children
- Medicine - Sep 27 Depression in pregnancy increases risk of mental health problems in children
- Medicine - Sep 27 UK lags behind Europe in supporting and prolonging cycling among older population
- Medicine - Sep 27 Rest and well- being – world’s largest survey
- Medicine - Sep 27 Are suburban garden ponds spreading lethal frog disease?
- Medicine - Sep 27 Outdoor air pollution exceeds WHO limits for 90% of UK population
- Medicine - Sep 27 Researchers close in on new ways to prevent child tooth decay
- Medicine - Sep 27 Study offers new data tool- kit for Ebola outbreak zones
- Medicine - Sep 26 BAME patients may be underrepresented in trials for diabetes treatment, study finds
- Life Sciences - Sep 26 An unobstructed view into the human body
- Medicine - Sep 26 Cancer killers: C’dots show ability to induce cell death in tumors
Stopping cell migration may help block fibrosis and the spread of cancer
Discoveries by a Yale-led team of scientists could lead the way for development of new therapies for treating fibrosis and tumor metastasis. The researchers have both uncovered a signaling pathway that promotes cell migration in certain forms of pulmonary fibrosis, a deadly lung disease, and developed a drug treatment that may block the cancer cell migration. The study appears in the Advance Online Publication of Nature Cell Biology.
Pulmonary fibrosis is the development of excessive connective tissue in the lungs. It can develop without a known cause, and produces permanent scar tissue in the lungs. There is no known cure or treatment to slow down its progress.
Cell migration is the biological process by which cells move around the body, often contributing to the development or spread of diseases such as fibrosis or metastatic cancer.
Fibroblast connective tissue cells and cancer cells migrate in a way that requires sustained activation of signaling pathways. But until now the regulation of these cellular functions has been poorly understood. The Yale team studied the workings of a stimulant of cell migration known as lysophosphatidic acid (LPA). They identified the chemical reactions that ultimately induce cell migration, but more importantly, discovered a way to block the pathway via inhibition of the proteins responsible for promoting the migration.
Senior author Dianqing (Dan) Wu, professor of pharmacology and vascular biology at Yale School of Medicine and member of Yale Cancer Center, explained, "Our ability to block the pathway provides a potential therapeutic target for treating pulmonary fibrosis, a very serious disease that lacks effective treatments, and other types of fibrosis. Because cancer cells, particularly melanoma and lung cancer cells containing activated BRAF genetic mutations, can use this signaling pathway to migrate, blocking this pathway could also prevent metastasis of these cancers."
Other authors are Xiaoqing Gan, Jiyong Wang and Chen Wang of Yale; Eeva Sommer and Dario Alessi of the University of Dundee; Tohru Kozasa of the University of Illinois at Chicago; Srinivasa Srinivasula of the National Cancer Institute; Stefan Offermanns of the Max-Planck-Institute for Heart and Lung Research; and Melvin I. Simon of the University of California at San Diego.
Last job offers
- Medicine/Pharmacology - 15.9
Leiter/in Forschung & Entwicklung Pflege (Professorenstelle)
- Medicine/Pharmacology - 15.9
Leiter/in des Studiengangs Master of Science in Pflege
- Life Sciences - 14.9
Einstieg für Naturwissenschaftler / Biologen in die IT-Consulting Welt
- Life Sciences - 11.9
Postdoctoral Research Fellowship
- Environment - 9.9
Leiter/in der Forschungsgruppe Vegetationsökologie
- Medicine/Pharmacology - 7.9
Software Systems Requirements Engineer - Medical Device
- Medicine/Pharmacology - 27.9
Postdoc Vaccine development IBV (1.0 fte)
- Life Sciences - 27.9
Postdoc in Computational Proteomics: Temporal Profiling of Protein Networks and their Regulation